Table 2 Awareness, treatment and control of hypertension, dyslipidemia and obesity by glycemic status.

From: The prevalence of pre-diabetes and diabetes and their associated factors in Northeast China: a cross-sectional study

Items*

Glycemic status

Normal glucose regulation (n, %) (n = 12765)

Pre-diabetes (n,%) (n = 3641)

Previously-diagnosed diabetes (n, %) (n = 1347)

Newly-diagnosed diabetes (n %) (n = 609)

Hypertension

Prevalence

3989 (31.2)

1621 (44.5)

840 (62.4)

339 (55.7)

Awareness

1793 (44.9)

693 (42.8)

578 (68.8)

169 (49.9)

Treatment

1503 (83.8)

569 (82.1)

510 (88.2)

143 (84.6)

Control

411 (27.3)

127 (22.3)

63 (12.4)

20 (14.0)

Dyslipidemia

Prevalence

3959 (31.0)

1713 (47.0)

769 (57.1)

217 (35.6)

Awareness

395 (10.0)

119 (6.9)

140 (18.2)

37 (17.1)

Treatment

121 (30.6)

45 (37.8)

75 (53.6)

9 (24.3)

Control

6 (5.0)

2 (4.4)

3 (4.0)

0 (0)

Obesity

Prevalence

1567 (12.3)

733 (20.1)

329 (24.4)

137 (22.5)

Awareness

1368 (87.3)

629 (85.8)

263 (79.9)

124 (90.5)

Treatment

439 (32.1)

196 (31.2)

79 (30.0)

34 (27.4)

Control

114 (26.0)

63 (32.1)

29 (36.7)

8 (23.5)

  1. *“Awareness” refers to how many people in the total number of patients know their condition. “Treatment” refers to how many people who know their condition and take treatment measures. “Control” refers to how many of the people who have taken measures have been effectively controlled.